Literature DB >> 15022800

Factors predisposing to periprosthetic fracture after hip arthroplasty: a case (n = 31)-control study.

Roope Sarvilinna1, Heini S A Huhtala, Roope T Sovelius, Pekka J Halonen, Juha K Nevalainen, K Jorma K Pajamäki.   

Abstract

We compared retrospectively 31 patients with a periprosthetic fracture to 31 patients in a control group. The Finnish Arthroplasty Register was used to count all periprosthetic fractures treated by revision arthroplasty in Finland and in Tampere University Hospital district during the years 1990-1999. We used the date of the previous operation to find the control group patients operated on at the same time in the same hospital district. No other selection or matching criteria were used. The type of prosthesis, complications, age, BMI, cementation and primary diagnosis were compared. We found that patients who had a fracture as the primary diagnosis ran a 4.4 (95%CI = 1.4-14) times higher risk of periprosthetic fracture than those operated on for other reasons.

Entities:  

Mesh:

Year:  2004        PMID: 15022800     DOI: 10.1080/00016470410001708030

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  19 in total

Review 1.  Incidence and predisposing factors of periprosthetic proximal femoral fractures: a literature review.

Authors:  Claudia C Sidler-Maier; James P Waddell
Journal:  Int Orthop       Date:  2015-03-27       Impact factor: 3.075

2.  Prevalence and risk factors for intra-operative periprosthetic fractures in one thousand eight hundred and seventy two patients undergoing total hip arthroplasty: a cross-sectional study.

Authors:  Walter Ricioli; Marcelo Cavalheiro Queiroz; Rodrigo Pereira Guimarães; Emerson K Honda; Giancarlo Polesello; Patricia M de Moraes Barros Fucs
Journal:  Int Orthop       Date:  2015-08-23       Impact factor: 3.075

3.  Patient factors predict periprosthetic fractures after revision total hip arthroplasty.

Authors:  Jasvinder A Singh; Matthew R Jensen; David G Lewallen
Journal:  J Arthroplasty       Date:  2012-02-15       Impact factor: 4.757

Review 4.  [Periprosthetic fractures. An interdisciplinary challenge].

Authors:  R Stange; M J Raschke; T Fuchs
Journal:  Unfallchirurg       Date:  2011-08       Impact factor: 1.000

5.  Long, titanium, cemented stems decreased late periprosthetic fractures and revisions in patients with severe bone loss and previous revision.

Authors:  Philippe Hernigou; Hernigou Philippe; Nicolas Dupuys; Dupuys Nicolas; Jerome Delambre; Delambre Jerome; Isaac Guissou; Guissou Isaac; Alexandre Poignard; Poignard Alexandre; Jerome Allain; Allain Jerome; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2014-09-18       Impact factor: 3.075

6.  Are gender, comorbidity, and obesity risk factors for postoperative periprosthetic fractures after primary total hip arthroplasty?

Authors:  Jasvinder A Singh; Matthew R Jensen; Scott W Harmsen; David G Lewallen
Journal:  J Arthroplasty       Date:  2012-04-30       Impact factor: 4.757

7.  Hip resurfacing for rheumatoid arthritis: independent assessment of 11-year results from an international register.

Authors:  Tajeshwar S Aulakh; Jan H Kuiper; Josh Dixey; James B Richardson
Journal:  Int Orthop       Date:  2010-05-25       Impact factor: 3.075

Review 8.  [Periprosthetic fractures following total hip and knee arthroplasty: Risk factors, epidemiological aspects, diagnostics and classification systems].

Authors:  M Fuchs; C Perka; P von Roth
Journal:  Unfallchirurg       Date:  2016-03       Impact factor: 1.000

Review 9.  Post-operative peri-prosthetic fracture rates following the use of cemented polished taper-slip stems for primary total hip arthroplasty: a systematic review.

Authors:  Kwaku Baryeh; David H Sochart
Journal:  Arch Orthop Trauma Surg       Date:  2022-01-20       Impact factor: 3.067

10.  Peptic ulcer disease and heart disease are associated with periprosthetic fractures after total hip replacement.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  Acta Orthop       Date:  2012-08-20       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.